ArticleJournal of translational medicine2013

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.

Julien Laurent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.